secwatch / observer
8-K filed September 12, 2025, 7:59 PM ET ticker MYSZ CIK 0001211805
M&A confidence high sentiment positive materiality 0.65

My Size acquires ShoeSize.Me for $440K (cash+stock) plus warrant; adds AI footwear sizing

My Size, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-25-013135
form_type
8-K
ticker
MYSZ
cik
0001211805
company_name
My Size, Inc.
filed_at
2025-09-12T23:59:59+00:00
discovered_at
2026-05-14T18:02:43.512424+00:00
generated_at
2026-05-17T06:43:24.816421+00:00
sec_items
["1.01", "2.01", "3.02", "7.01", "9.01"]
event_type
m_and_a
sentiment
positive
materiality_score
0.65
calibrated_materiality_score
0.65
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-25-013135
json_url
https://secwatch.observer/filing/0001493152-25-013135.json
markdown_url
https://secwatch.observer/filing/0001493152-25-013135.md
text_url
https://secwatch.observer/filing/0001493152-25-013135.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1211805/000149315225013135/0001493152-25-013135-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1211805/000149315225013135/form8-k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

a1cb3740740d888ad3749ea27b037ec66d89bc77

My Size, Inc. completed an acquisition involving Sellers (holders of 100% of share capital of ShoeSize.Me AG) for a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock having an aggregate value of $290,000 (closed 2025-09-08).

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

NNE

Nano Nuclear acquires STS for up to $13M, adds nuclear logistics and $7.1M revenue

Nano Nuclear Energy Inc. May 29, 2026, 6:30 AM ET m_and_a Items 1.01, 2.01, 3.02, 5.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

“STS Acquisition”). The closing of the STS Acquisition occurred on May 22, 2026 (the “Closing Date”). Pursuant to the Purchase Agreement, the Buyer Parties agreed to pay up to $13.0 million in total consideration for STS, consisting of (i) approximately $6.0 million in cash (the “Closing Cash Consideration”), subject to adjustment under certain conditions within 180

Filing page SEC filing

RMIX

Suncrete completes acquisition of Hope Concrete (10 plants, 88 trucks) for $39.4M + equity

Suncrete, Inc. April 29, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

in its capacity as representative of the Sellers. After giving effect to the transactions contemplated by the Purchase Agreement, the aggregate consideration consisted of (i) 220,007 shares (the “Mikytuck Rollover Securities”) of Class A Common Stock, par value $0.0001 per share, of the Company (“Class A Common Stock”) issued to Mr. Mikytuck, (ii) 69,511

Filing page SEC filing

PHGE

BiomX accelerates option exercise, acquires 60% stake in DFSL for $750k cash, $3M note

BiomX Inc. April 13, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

delivery. In consideration for the Purchased Shares, the Company agreed to the following consideration to Mandragola: (i) a cash payment of Seven Hundred Fifty Thousand Dollars ($750,000), of which Four Hundred Fifty Thousand ($450,000) was advanced by the Company; (ii) the issuance of an unsecured convertible promissory note in the principal amount of Three

Filing page SEC filing

PHGE

BiomX acquires ZorroNet, enters AI defense with $1.25M note and stock

BiomX Inc. April 10, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

active engagements with Elbit Systems Ltd (TASE/Nasdaq: ESLT) and other top Israel’s preeminent defense prime contractors. As consideration, the Company issued to Water IO: (i) 1,300,000 shares of common stock ; and (ii) a non-convertible promissory note in the amount of $1,250,000 , bearing interest at the short-term applicable federal rate, payable July 7, 2026.

Filing page SEC filing

TBN

Tamboran completes acquisition of Falcon subsidiaries, now holds ~2.8M net acres in Beetaloo

Tamboran Resources Corp May 28, 2026, 10:23 AM ET m_and_a Items 2.01, 3.02, 7.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 3.02, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

Exploration and Production South Africa (Pty) Ltd, a company incorporated under the laws of South Africa. In exchange for the Subject Interests, Tamboran (a) issued to Falcon 6,537,503 shares (the “ Stock Consideration ”) of its common stock, par value $0.001 per share (the “ Tamboran Common Stock ”), and (b) paid $23,663,080 in cash (the “ Cash Consideration

Filing page SEC filing

TMGI

TMGI acquires CSTI in all-stock deal, 50.6M shares issued

Transglobal Management Group, Inc. May 27, 2026, 7:04 PM ET m_and_a Items 1.01, 2.01, 3.02, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

Exchange Agreement (the “Agreement”) to acquire all of the outstanding shares of Continuum Software Technologies, Inc., a Wyoming corporation (hereafter, “CSTI”), in exchange for 50,645,000 shares of common stock (the “TMGI Common Stock”) of the Company (such transaction is hereafter referred to as the “Acquisition”). CSTI possesses a cloud-based, all-in-one golf

Filing page SEC filing

ACNT

Ascent Industries acquires Midwest Graphic/Sigma for $14M; Q1 net sales up 9% to $19.4M but adjusted EBITDA loss widens

ASCENT INDUSTRIES CO. May 6, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 2.02, 7.01, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

the Company purchased substantially all of the assets and certain specified liabilities of Seller for $14,000,000, subject to certain customary adjustments for working capital, transaction expenses, and cash, on the terms and subject to the conditions set forth in the Purchase Agreement (the “Transaction”). The Transaction closed simultaneously with the execution of the Purchase Agreement.

Filing page SEC filing

OTLC

Oncotelic completes merger transferring patent portfolio to Lunai for $20M Series B Preferred stock

Oncotelic Therapeutics, Inc. May 5, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 9.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 3.02, 9.01 same event type: m_and_a similar materiality

This filing

day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the

Comparable filing

greement and Plan of Merger (the “Merger Agreement”) with Lunai Bioworks, Inc., a Delaware corporation (“Lunai”), Lunai Bioworks IP, Inc., a Delaware corporation and a wholly owned subsidiary of Lunai (“Merger Sub”), Neurobridge IP Holdings

Filing page SEC filing

Source: SEC EDGAR
accession 0001493152-25-013135

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.